Medtronic CEO Geoff Martha told analysts Tuesday during the company's fiscal Q3 2021 earnings call that the diabetes business unit is making considerable progress in its turnaround efforts, and actually returned to growth during the quarter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,